A computational study of the resistance of HIV-1 aspartic protease to the inhibitors ABT-538 and VX-478 and design of new analogues

Biochemical and Biophysical Research Communications

Volumn 242, Issue 3, 1998, Pages 545-551

  Nair, Anil C ^a,b,c   Miertus, Stanislav ^a,b   Tossi, Alessandro ^d   Romeo, Domenico ^d  

^a UNIDO   (Italy)

^b POLY Tech SCRL   (Italy)

^c BANARAS HINDU UNIVERSITY   (India)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ASPARTIC PROTEINASE; RITONAVIR;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CROSS RESISTANCE; DRUG DESIGN; ENZYME ACTIVE SITE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DOMAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032567678     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.8008     Document Type: Article

References (28)

1. Condra J. H., Schleif W. A., Blahy O. M., Gadryelski L. J., Graham D. J., Quintero J. C., Rhodes A., Robbins H. L., Roth E., Shivaprahash M., Titus D., Yang T., Teppler H., Squires K. E., Deutsch P. J., Emini E. A. Nature. 374:1995;569-571.
2. Schock H. B., Garsky V. M., Kuo L. C. J. Biol. Chem. 271:1996;31957-31963.
3. Chen Z., Li Y., Schock H. B., Hall D., Chen E., Kuo L. C. J. Biol. Chem. 270:1995;21433-21436.
4. Otto M. J., Garber S., Winslow D. L., Reid C. D., Aldrich P., Jadhav P. K., Patterson C. E., Hodge C. N., Cheng Y-S. Proc. Natl. Acad. Sc. U. S. AU. S. 90:1993;7543-7547.
5. Kaplan A. H., Michael S. F., Wehbie R. S., Knigge M. F., Paul D. A., Everitt L., Kempf D. J., Norbeck D. W., Erickson J. W., Swanstrom R. Proc. Natl. Acad. Sci. U. S. AU. S. 91:1994;5597-5601.
6. El-Farrash M. A., Kuroda M. J., Kitazaki T., Masuda T., Kato K., Hatanaka M., Harada S. J. Virol. 68:1994;233-239.
7. Coffin J. M. Science. 267:1995;483-489.
8. Pazhanisamy S., Sttuver C. M., Cullinan A. B., Margolin N., Rao B. G., Livingston D. J. J. Biol. Chem. 271:1996;17979-17985.
9. Ho D. D., Toyoshima T., Mo H, Kempf D. J., Norbeck D., Chen C-M., Wideberg N. E., Burt S. K., Erickson J. W., Singh M. K. J. Virol. 68:1994;2016-2020.
10. Maschera B., Darby G., Palu G., Wright L. L., Tisdale M., Myers R., Blair E. D., Furfine E. S. J. Biol. Chem. 271:1996;33231-33235.
11. Gulnik S. V., Suvorov L. I., Liu B., Yu B., Anderson B., Mitsuya H., Erickson J. W. Biochemistry. 34:1995;9282-9287.
12. Husson R. N., Shirasaka T., Butler K. M., Pizzo P. A., Mitsuya H. J. Pediatr. 123:1993;9-16.
13. Richman D. D. Textbook of AIDS Medicine. 1994;Williams and Wilkins, Baltimore. p. 795-805.
14. Baldwin E. T., Bhat T. N., Liu B., Pattabiraman N., Erickson J. W. Nature Struct. Biol. 2:1995;244-249.
15. Rose R. E., Gong Y., Greytog J. A., Bechtold C. M., Terry B. J., Robinson B. S., Alam M., Colonno R. J., Lin P. Proc. Natl. Acad. Sci. U.S.A. 93:1995;1648-1653.
16. Miertus S., Frecer V. Palma M. U., Palma M. B., Parak F. Water-Biomolecule Interactions. 1993;195-200 SIF, Bologna.
17. Miertus S. Bioorg. Med. Chem. Lett. 3:1993;2105-2112.
18. Miertus S., Antcheva N., Tossi A., Bizik F., Benedetti F., Gennaro R., Romeo D. Sanz F., Giraldo J., Manaut F. QSAR and Molecular Modelling: Concepts, Computational Tools and Biological Applications. 1995;579-582 Prous Science, Barcelona.
19. Tossi A., Antcheva N., Romeo D., Miertus S. Peptide Res. 8:1995;2-8.
20. Miertus S., Furlan M., Tossi A., Romeo D. Chem Phys. 204:1996;173-180.
21. Frecer V, Miertus S., Tossi A., Romeo D. Drug Design and Discovery. 1997.
22. Nair, A. C. Frecer, V. Miertus, S. Tossi, A. Palù, G. Romeo, D. 1997.
23. Discover, Biosym/MSI, San Diego, CA.
24. Insight II, Biosym/MSI, San Diego, CA.
25. Bhat, T. N. Hosur, M. V. Baldwin, E. T. Erickson, J. W. A76928 - HIV-1 Aspartic Protease complex crystal structure.
26. Kim, E. E. VX-478 - HIV-1 Aspartic Protease complex crystal structure.
27. Schechter I., Berger A. Biochem. Biophys. Res. Commun. 27:1967;157-163.
28. Ridky T., Leis J. J. Biol. Chem. 270:1995;29621-29623.